Carfilzomib

ATC L01XG02 · 10 markets · 35 records

Carfilzomib 10 markets · 35 records Forms

ES 9 records · 3 strengths

AU 7 records · 4 strengths

  • 30 mginjectionKYPROLISKYPROLIS carfilzomib 30 mg powder for injection vial also in ES·GB·TW +1 unknown
  • 60 mginjectionKYPROLISKYPROLIS carfilzomib 30 mg powder for injection vial also in ES·GB·CN unknown
  • 10 mginjectionKYPROLISKYPROLIS carfilzomib 30 mg powder for injection vial also in ES·GB unknown

Records without a stated strength · 1 KYPROLIS

GB 4 records · 3 strengths

US 3 records · 3 strengths

CA 3 records · 3 strengths

TW 3 records · 2 strengths

  • 30 mginjectionKyprolis forMyeloPro for Injection 30 mg、凱博斯凍晶注射劑30毫克、骨樂博凍晶注射劑30毫克 also in ES·AU·GB +1

Records without a stated strength · 1 Kyprolis for injection、凱博斯凍晶注射劑

SG 2 records · 2 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 KYPROLIS FOR INJECTION 30MG/VIAL

    CN 1 records · 1 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 KYPROLIS

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

      A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.